Midatech Pharma (LON:MTPH) Shares Down 10.3%

Midatech Pharma PLC (LON:MTPH) dropped 10.3% during trading on Thursday . The stock traded as low as GBX 2.50 ($0.03) and last traded at GBX 2.60 ($0.03), approximately 1,977,017 shares traded hands during trading. An increase of 3,096% from the average daily volume of 61,863 shares. The stock had previously closed at GBX 2.90 ($0.04).

The company has a quick ratio of 3.83, a current ratio of 4.21 and a debt-to-equity ratio of 4.42. The stock has a market cap of $12.22 million and a price-to-earnings ratio of -0.59. The company has a 50 day simple moving average of GBX 3.06 and a 200 day simple moving average of GBX 4.28.

About Midatech Pharma (LON:MTPH)

Midatech Pharma PLC, a specialty pharmaceutical company, focuses on developing and commercializing products in oncology and immunotherapy in the United States and the United Kingdom. The company operates through two segments, Pipeline Research and Development; and Commercial. Its products include Zuplenz, an oral soluble film for moderately emetogenic chemotherapy-induced nausea and vomiting, radiotherapy-induced nausea and vomiting, and post-operative nausea and vomiting; Gelclair, an oral gel barrier device indicated for the management and relief of pain due to oral mucositis; Oravig, an orally dissolving buccal tablet for oral thrush; and Soltamox, an oral liquid solution of tamoxifen citrate, for the treatment and prevention of breast cancer.

Further Reading: How prevalent are 12b-1 fees?

Receive News & Ratings for Midatech Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Midatech Pharma and related companies with MarketBeat.com's FREE daily email newsletter.